Redeye: Hanza - Softer Market and Integrations Hurting Short-Term
Redeye retains its positive stance towards Hanza despite a softer Q1 report than expected, resulting in lowered forecasts and Base Case. The softer market and the integration of Orbit One are hurting margins somewhat more than we anticipated, reducing our short-term forecasts. On the other hand, management seems very confident in the 2025 targets despite the somewhat softer market.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/